EMD Millipore Announces Strategic Alliance on Biopharmaceutical Manufacturing
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced that EMD Millipore and Samsung BioLogics have signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business. The alliance is intended to encompass a long-term supply agreement in which EMD Millipore will provide raw materials for biopharmaceutical manufacturing.
Dr. Udit Batra, President and CEO of EMD Millipore, and Benoit Gourdier, Head of EMD Millipore’s Process Solutions Asia, were present at the signing ceremony held at Samsung BioLogics’ headquarters in Korea. “Our latest partnership in the biopharmaceutical sector will further strengthen the great relationship Merck KGaA and Samsung have built in other business areas for the past years. It will also help us support Samsung’s initiative in the CMO and biopharmaceutical field,” said Dr. Batra.
EMD Millipore will become an essential raw material supplier for Samsung BioLogics’ 30KL facility as well as its new 150KL facility that is expected to be completed in 2015 at Songdo, Incheon, Korea.
“Samsung BioLogics is delighted to develop a strategic alliance with EMD Millipore, which will not only provide us a stable supply of crucial raw materials but also bring mutual advantages for both companies’ long-term business strategies and competitiveness in the biopharmaceutical industry,” said Dr. TH Kim, President and CEO of Samsung BioLogics.
Samsung BioLogics is a global full-service provider of quality-driven contract process development and cGMP manufacturing to the global biopharmaceutical industry. Its facilities are custom designed for monoclonal and recombinant production with maximum flexibility. Its one-stop services include cell line generation, process and analytical method development, analytical services, clinical and commercial bulk cGMP manufacturing of drug substance and drug product including quality assurance, quality control, regulatory compliance standards and support for our customers. For more information, visit www.samsungbiologics.com.
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services, and business relationships that enable customers’ success in research, development, and production of biotech and pharmaceutical drug therapies. For more information, visit www.emdmillipore.com.
Total Page Views: 939
